A new risk model may help identify which patients with chronic kidney disease (CKD) and diabetes are more likely to develop hyperkalemia, granting physicians more confidence in prescribing medications ...

Between 2016 and 2024, the prevalence of CKD increased from 20.5% to 26.4% in T1D and from 24.8% to 37.3% in T2D. The annual incidence of CKD declined in both diabetes types: T1D fell from 21.5 to ...

Please provide your email address to receive an email when new articles are posted on . General health scores significantly improved in the semaglutide group compared with placebo. Patients treated ...

Chronic kidney disease is a common complication of type 2 diabetes, but not everyone with diabetes develops it. Certain risk factors, like diabetic neuropathy and hypertension, can increase the chance ...

Please provide your email address to receive an email when new articles are posted on . Of 11,758 patients with CKD, diabetes and hypertension in the study, researchers found 1,285 cases of dementia.

New findings from the landmark FLOW trial, presented at the 63 rd ERA Congress, show that once-weekly semaglutide significantly improved health-related quality of life in adults with type 2 diabetes ...

Chronic kidney disease (CKD) is common, largely silent and serious. Most people who have the condition do not realize they have it, while it sharply raises the risk of heart attacks, strokes, kidney ...

Higher sKlotho levels are linked to lower CKD prevalence in individuals with diabetes and hypertension, but not in those without hypertension. The study suggests a synergistic effect between low ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

People with diabetes have a higher risk of many different health issues, including kidney and heart problems. Although various medicines can help reduce the risk of these issues, many people with ...